News & Information | START In The News

May 30th, 2013

START to present an impressive number of abstracts of Phase I clinical trials data at ASCO 2013

(SAN ANTONIO, TX) - South Texas Accelerated Research Therapeutics (START), with clinic sites in San Antonio, Texas, Madrid, Spain and Shanghai, China, announced today that 15 abstracts, submitted by START physicians and researchers, have been accepted for presentation at the 2013 ASCO (American Society of Clinical Oncology) Annual Meeting which will be held May 31-June 4, 2013 in Chicago.

ASCO is the world's leading professional organization representing physicians who care for people with cancer. The ASCO Annual Meeting brings together more than 25,000 oncology professionals from a broad range of specialties. This year's conference theme is Building Bridges to Conquer Cancer

With their global network of sites, START conducts the world's largest -- and the only 24-hour -- Phase I medical oncology program.

 "This is an outstanding accomplishment for any institution involved in clinical cancer research in the world and reflects the hard work of START researchers throughout the world," said   START's director of clinical research, Anthony W. Tolcher, MD. 

The mission of START is to accelerate the development of new anticancer drugs with the purpose of improving quality of life and survival for patients with cancer. START operates under the clinical leadership of Dr. Anthony W. Tolcher, Dr. Amita Patnaik and Dr. Kyriakos P. Papadopoulos and consists of a team of highly trained staff with extensive experience in Phase I clinical trials research.Access to abstracts to be presented by START researchers is available at www.asco.org.

ABOUT START

START is a global, 24-hour Phase I research organization focused on accelerating the development of new anticancer drugs with the purpose of improving quality of life and survival for patients with cancer. START operates under the leadership of Dr. Anthony W. Tolcher, Dr. Amita Patnaik and Dr. Kyriakos P. Papadopoulos and consists of a team of highly trained staff with extensive experience in Phase I clinical trials research. For more information please visit www.startthecure.com. For information on START Shanghai, visit www.startshanghai.cn and for information on START Madrid visit www.startmadrid.com.